ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_16105_27 # 29124 # 31133 # -1 # ID=80_27;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.466	k141_16105_27	29124	31133	-	Strict	300	303.523	poxtA	35.5	3004470	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGATATTATCCTGCAGTAATATCTGCAAGTCATTTGGGGAAAATGACATTTTAAAGCAGGTTTCTTTCCATATAGAAGATCACGAAAAAGCGGCGATCGTAGGCATCAATGGCGCCGGAAAATCCACTCTTTTAAAGGTACTTATCGGGAAACTGGCCGCAGATGACGGCGTTGTTACCTGGGCAAAGGGTGCTTCCATTGGTTACCTGGCCCAGCATCAGGATCTGGAGGGGGCTGAAACTATTTACGATGCCCTTTTAGAGGTGAAAAAACCAGTGATCCAGATGGAGGCCCGCATCCGCAGCCTGGAACTGGAAATGAAATCCGCTTCCGGTGATGAATTAGAGGCCAAGCTTTCTGAATACAGCCGGTTAAACCATGAATTTGAAATGGCAGACGGTTATTCCTACCAAAGCGAGATCACCGGTGTTTTAAAGGGTCTCGGATTTACAGAGGATGAATTTTCCAAACCCATCACTGCTCTCTCAGGCGGCCAGAAGACCCGCGTTTCCTTAGGCAAGCTGCTGCTTACCAAACCAGACATCCTGCTTCTGGACGAGCCTACCAACCACCTGGATATGGAGTCCATCGCATGGTTAGAAACTTATCTGAGAAACTACAGCGGTGCTGTGATCATCGTTGCCCATGACCGGTATTTCCTGGACCGTGTGGTAACAAAGATCATTGAACTGGACATGGGGCATTGTACTGTATTTTCAGGAAATTATTCTGCCTACAGCAATAAAAAGGCCATGCTCCGCGATGCTGCCATCCGTGCCTATTTAAACCAGCAGCAGGAGATTCGTCACCAGGAAGCTGTTATTGCCAAATTAAAGTCCTTTAACCGTGAGAAGTCCATTAAGCGGGCAGAAAGCCGTGAAAAGATGCTGGATAAGATCGATCGTCTGGAAAAACCTGTACAGACAAATGATTCCATGGATATCCGCCTGGAACCGGATGTAGTCAGTGGAAATGATGTTCTGACAGTTACTGGGCTAAGCAAATCCTTTGACACACAGACACTGTTTACCAATGTGGATTTTGAGATCAAACGGGGAGAACGGGTTGCTGTTATTGGAAATAACGGTACTGGCAAGACTACTCTTTTAAAGATCATCAATGGCATCATCCCTGCAGATTCCGGTCAGATCCGTTTGGGTTCCAAAGTGCATATTGGCTACTACGATCAGGAACACCAGGTACTTCACATGGACAAGACCCTGTTCCAGGAAATACAGGACACGTATCCAAACATGAACAATACCCAGATCCGCAATACACTGGCAGCTTTCCTTTTTACAGGAGATGACGTATTTAAGCTGATCCGGGATTTAAGCGGTGGGGAACGAGGCCGTGTTTCCCTTGCGAAATTAATGCTCTCTGATGCTAATTTCCTGCTTCTGGACGAGCCTACCAACCACCTGGACATCACCTCCAAGGAGATCCTTGAAAGTGCTTTAAACCGCTATACAGGAACAGTATTGTATGTGTCCCATGACCGTTACTTTATCAACCGTACTGCTACCCGAATCCTGGATCTGACAAATGGTTCATTTATCAACTATATCGGCAATTATGACTATTATCTGGAGAAAAAAGAAGATGTAGAAGCTGCCTTTGCCGCAAGACAGATGGCCCAGACTGCAGCTAACCATCCAACCGGTACAAACAGCCCGCAGGCAACCAGTACTGCCTCCGGCATATCTTCAAGCCGTACTTCCCAGACAGCTATGACCGCCTCCTCTGCCGGCTCTCCTGCTGACGGAAAAATAGACTGGAAAGCCCAGAAAGAAGAACAGGCCCGTCTTCGCAAACGCCAGAATGAACTTAAAAAAATTGAGGATAAGATCCATGAGCTTGAAACAAGGGATGGCGAGATCGATGAGCTCCTCTCCCAGGAAGATGTATATACCGATGTTTCCCGCCTTATGGAGCTGAACAAAGAGAAAGAATCCATTCAGAAAGAACTGGAAGTTCTCTATGAGAAATGGGAAGAACTGGCAGAATAA	MILSCSNICKSFGENDILKQVSFHIEDHEKAAIVGINGAGKSTLLKVLIGKLAADDGVVTWAKGASIGYLAQHQDLEGAETIYDALLEVKKPVIQMEARIRSLELEMKSASGDELEAKLSEYSRLNHEFEMADGYSYQSEITGVLKGLGFTEDEFSKPITALSGGQKTRVSLGKLLLTKPDILLLDEPTNHLDMESIAWLETYLRNYSGAVIIVAHDRYFLDRVVTKIIELDMGHCTVFSGNYSAYSNKKAMLRDAAIRAYLNQQQEIRHQEAVIAKLKSFNREKSIKRAESREKMLDKIDRLEKPVQTNDSMDIRLEPDVVSGNDVLTVTGLSKSFDTQTLFTNVDFEIKRGERVAVIGNNGTGKTTLLKIINGIIPADSGQIRLGSKVHIGYYDQEHQVLHMDKTLFQEIQDTYPNMNNTQIRNTLAAFLFTGDDVFKLIRDLSGGERGRVSLAKLMLSDANFLLLDEPTNHLDITSKEILESALNRYTGTVLYVSHDRYFINRTATRILDLTNGSFINYIGNYDYYLEKKEDVEAAFAARQMAQTAANHPTGTNSPQATSTASGISSSRTSQTAMTASSAGSPADGKIDWKAQKEEQARLRKRQNELKKIEDKIHELETRDGEIDELLSQEDVYTDVSRLMELNKEKESIQKELEVLYEKWEELAE	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	123.43	gnl|BL_ORD_ID|2577|hsp_num:0	2904		
